Fulminant Devic disease successfully treated by lymphocytapheresis.
Nozaki
I
I
Hamaguchi
T
T
Komai
K
K
Yamada
M
M
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016207:Cytokines / Q000032:analysis; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007937:Leukapheresis; D008775:Methylprednisolone / Q000627:therapeutic use; D009471:Neuromyelitis Optica / Q000276:immunology / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone